Post

Generics expected to improve access for patients with idiopathic pulmonary fibrosis

The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments that are available globally, Roche’s Esbriet/Pirespa …

Mobile health strategies: Should you build or partner for success?

As the digital transformation of healthcare continues to gather pace, the explosion of digital health solutions is hard to ignore. …

UKHSA signs influenza vaccine deal with CSL Seqirus

The UK Health Security Agency (UKHSA) has signed an advance purchase agreement with healthcare company CSL Seqirus for influenza pandemic …

Arcturus Therapeutics extends cystic fibrosis treatment deal

Arcturus Therapeutics has extended an existing agreement with the Cystic Fibrosis (CF) Foundation for advancing ARCT-032. ARCT-032 is an investigational messenger …

MilliporeSigma opens two new mRNA manufacturing facilities in Germany

Merck’s Life Science business MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany. Developed with …